UCT to host fourth multidrug-resistant TB conference

"The Global Ministerial Conference will highlight the need for an accelerated multisectoral response to TB in the context of the Sustainable Development Goals", said Dr Ren Minghui, Assistant Director-General HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases.

Fourth, strengthening of the laudable community-based health initiatives in the country to facilitate more community participation, ownership and actions to increase the geographic coverage of TB interventions.

In 2015, there were an estimated 10.4 million new TB cases worldwide.

According to the Uganda National TB and Leprosy Program records, in 2016, only 420 drug resistant TB patients were notified out of the expected 2600; suggesting that up to 84% of all the drug resistant TB patients were not notified. As such, billions of dollars are spent every year improving medical care for people living with HIV and fighting the opportunistic infections - foremost, tuberculosis - that continue to kill so many AIDS patients.

"TB exists on an epic scale in India, and cases of multidrug resistant TB are an increasing concern". This year's motto is "Unite to end TB".

In Singapore, however, virtually all patients with TB and even the rare few with MDR-TB have access to quality care, with social support provided to low-income patients to maximise the likelihood of treatment completion.

The Centre for Disease Dynamics, Economics and Policy (CDDEP) researchers have published their study in The International Journal of Tuberculosis and Lung Disease.The researchers of the new study have developed an approach to estimate the extent of TB in India using previous estimates from nearby countries and a current understanding of the TB transmission.

He added that patients approaching practitioners in alternate health systems such as homeopathy and ayurveda for treatment is also an area of concern because TB can not be treated by these therapies.

TB can be viewed as a crude microcosm of Singapore's development.

Most people still believe TB is a poor man's disease, but they're wrong.

The surveys have noted a rise in TB cases between the age group of 16 to 30.

The neglect and invisibility of these lesser-known mycobacteria, zoonotic forms of tuberculosis and extrapulmonary TB cases result, paradoxically, from the incredible success of global TB control efforts focused on the elimination and treatment of pulmonary cases of Mycobacterium tuberculosis and on TB in populations with a high HIV/AIDS burden.

Continuous political goodwill is needed to ensure that the required financial and human resources for TB prevention and control are available to the national TB programme; academic institutions should engage in further research into innovative home-grown strategies for ending the scourge.

"What we are looking at is rapid decline in TB morbidity, and mortality".

The theme of the 2017 TB Day is therefore very instructive and one that inspires a call for concerted efforts from all stakeholders to achieve Rwanda's vision of a TB-free country.

TB has been treated since the 1950s with a combination of three antibiotics. The lack of knowledge about the existence and spread of zoonotic mycobacteria is largely due to the fact that they remain some of the most hard pathogens to detect.

The bacteria of TB affects the lungs and due to this risky disease, millions of people die every year. Early detection of TB means better and faster cure. GeneXpert helps in detecting drug-resistant TB within two hours.

A National Tuberculosis Control Programme (NTP) report states that the percentage of children infected with TB rose from 4% in 2015 to 4.3% in 2016 and the total number of TB patients increased from 57% to 61% between 2015 and 2016.

  • Joanne Flowers